Anti-ACHB3/ CHRNB3 monoclonal antibody

Anti-ACHB3/ CHRNB3 antibody for FACS & in-vivo assay

Target products collectionGo to CHRNB3/CHRNB3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0262-Ab-1/ GM-Tg-hg-MP0262-Ab-2Anti-Human CHRNB3 monoclonal antibodyHuman
GM-Tg-rg-MP0262-Ab-1/ GM-Tg-rg-MP0262-Ab-2Anti-Rat CHRNB3 monoclonal antibodyRat
GM-Tg-mg-MP0262-Ab-1/ GM-Tg-mg-MP0262-Ab-2Anti-Mouse CHRNB3 monoclonal antibodyMouse
GM-Tg-cynog-MP0262-Ab-1/ GM-Tg-cynog-MP0262-Ab-2Anti-Cynomolgus/ Rhesus macaque CHRNB3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0262-Ab-1/ GM-Tg-felg-MP0262-Ab-2Anti-Feline CHRNB3 monoclonal antibodyFeline
GM-Tg-cang-MP0262-Ab-1/ GM-Tg-cang-MP0262-Ab-2Anti-Canine CHRNB3 monoclonal antibodyCanine
GM-Tg-bovg-MP0262-Ab-1/ GM-Tg-bovg-MP0262-Ab-2Anti-Bovine CHRNB3 monoclonal antibodyBovine
GM-Tg-equg-MP0262-Ab-1/ GM-Tg-equg-MP0262-Ab-2Anti-Equine CHRNB3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0262-Ab-1/ GM-Tg-hg-MP0262-Ab-2; GM-Tg-rg-MP0262-Ab-1/ GM-Tg-rg-MP0262-Ab-2;
GM-Tg-mg-MP0262-Ab-1/ GM-Tg-mg-MP0262-Ab-2; GM-Tg-cynog-MP0262-Ab-1/ GM-Tg-cynog-MP0262-Ab-2;
GM-Tg-felg-MP0262-Ab-1/ GM-Tg-felg-MP0262-Ab-2; GM-Tg-cang-MP0262-Ab-1/ GM-Tg-cang-MP0262-Ab-2;
GM-Tg-bovg-MP0262-Ab-1/ GM-Tg-bovg-MP0262-Ab-2; GM-Tg-equg-MP0262-Ab-1/ GM-Tg-equg-MP0262-Ab-2
Products NameAnti-CHRNB3 monoclonal antibody
Formatmab
Target NameCHRNB3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHRNB3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ACHB3/ CHRNB3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003723human CHRNB3 Lentivirus plasmid
    ORF Viral VectorvGMLP003723human CHRNB3 Lentivirus particle
    ORF Viral VectorpGMLPm002949mouse Chrnb3 Lentivirus plasmid
    ORF Viral VectorvGMLPm002949mouse Chrnb3 Lentivirus particle


    Target information

    Target IDGM-MP0262
    Target NameCHRNB3
    Gene ID1142,108043,171131,720301,482837,101098624,521702,100054095
    Gene Symbol and Synonyms5730417K16Rik,Acrb3,CHRNB3,nicb3
    Uniprot AccessionQ05901,P12391
    Uniprot Entry NameACHB3_HUMAN,ACHB3_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000147432
    Target ClassificationN/A

    The target: CHRNB3, gene name: CHRNB3, also named as . The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are (hetero)pentamers composed of homologous subunits. The subunits that make up the muscle and neuronal forms of nAChRs are encoded by separate genes and have different primary structure. There are several subtypes of neuronal nAChRs that vary based on which homologous subunits are arranged around the central channel. They are classified as alpha-subunits if, like muscle alpha-1 (MIM 100690), they have a pair of adjacent cysteines as part of the presumed acetylcholine binding site. Subunits lacking these cysteine residues are classified as beta-subunits (Groot Kormelink and Luyten, 1997.



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.